IndexIQ Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$230K Buy
3,298
+438
+15% +$32K 0.01% 1016
2021
Q4
$223K Sell
2,860
-97
-3% -$8.56K 0.01% 1020
2021
Q3
$282K Buy
2,957
+188
+7% +$19.9K 0.01% 995
2021
Q2
$344K Buy
+2,769
New +$330K 0.01% 924

Other funds holding EXAS

IndexIQ Advisors's EXAS Position: Q1 2022 in Review

IndexIQ Advisors increased its Exact Sciences (EXAS) stake by 15% in Q1 2022, buying an estimated $32K and bringing the position to 3,298 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #1016.

IndexIQ Advisors first reported a position in EXAS in Q2 2021 and has held it in 4 quarters since. The position peaked at $344K in Q2 2021. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • IndexIQ Advisors held 3,298 shares of Exact Sciences worth $230K as of Q1 2022.
  • IndexIQ Advisors bought 438 Exact Sciences shares in Q1 2022, an estimated $32K.
  • Exact Sciences made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #1016 holding.
  • IndexIQ Advisors first reported a position in Exact Sciences in Q2 2021 and has held it in 4 quarters since.
  • IndexIQ Advisors's Exact Sciences position peaked at $344K in Q2 2021.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.